Signition LP’s DexCom DXCM Stock Holding History

Signition LP’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-8,200	Closed	-$244K	–	186
2019 Q1	$244K	Buy	+8,200	New	+$288K	0.17%	130

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Signition LP's DXCM Position: Q2 2019 in Review

Signition LP sold out of DexCom (DXCM) in Q2 2019, closing a stake of 8,200 shares — an estimated $244K sold.

Signition LP first reported a position in DXCM in Q1 2019 and held it in 1 quarter. The position peaked at $244K in Q1 2019. 418 funds tracked by Wall St. Rank hold DXCM as of Q2 2019.

Signition LP reported no remaining DexCom position as of Q2 2019 after selling out during the quarter.
Signition LP sold 8,200 DexCom shares in Q2 2019, an estimated $244K.
Signition LP first reported a position in DexCom in Q1 2019 and held it in 1 quarter.
Signition LP's DexCom position peaked at $244K in Q1 2019.
418 funds tracked by Wall St. Rank held DexCom as of Q2 2019.

Based on Signition LP's 13F filing for Q2 2019, filed 6 Aug 2019.